1-4 of 4
Agnes van Horssen
Close
Sort by
Journal Articles

Aberrant Expression in Human Epithelial Cancers of the P2X5-Encoded Minor Histocompatibility Antigen LRH-1: Implications for Graft-Versus-Tumor Immunity Against Solid Tumors.

Harry Dolstra, PhD, Henriette Levenga, MD, Ingrid Overes, MSc, Johanna C.M. Vos, BSc, Agnes van Horssen-Zoetbrood, BSc, Robbert van der Voort, PhD, Pieter de Mulder, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1795.
https://doi.org/10.1182/blood.V110.11.1795.1795
Published: 2007
Journal Articles

Use of RNA Electroporated DC for Activation of LRH-1 Specific Cytotoxic T Lymphocytes in the Treatment of Lymphoid Malignancies.

Ingrid Overes, Hanny Fredrix, Bjorn de Rijke, Agnes van Horssen-Zoetbrood, Han van Krieken, Reinier Raymakers, Robbert van der Voort, T.M. de Witte, Harry Dolstra
Journal: Blood
Blood (2006) 108 (11): 138.
https://doi.org/10.1182/blood.V108.11.138.138
Published: 2006
Journal Articles

Human CD34+ Myeloid Leukemic Progenitor Cells Are Susceptible to Lysis by Minor Histocompatibility Antigen LRH-1-Specific Cytotoxic T Lymphocytes.

Harry Dolstra, PhD, Ingrid Overes, Inge Jedema, PhD, Annemieke Vos, Agnes van Horssen-Zoetbrood, Wieger Norde, Robbert van der Voort, PhD, J.H. Frederik Falkenburg, MD, PhD, Anton V. Schattenberg, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 134.
https://doi.org/10.1182/blood.V108.11.134.134
Published: 2006
Journal Articles

A Novel Tissue-Restricted Minor Histocompatibility Antigen Resulting from Differential Expression Due to a Deletion/Insertion Polymorphism in the P2X5 Purinergic Receptor Gene.

Harry Dolstra, PhD, Bjorn de Rijke, Agnes van Horssen, Frans Maas, Britt Otterud, PhD, Elly van de Wiel-van Kemenade, PhD, Theo De Witte, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3062.
https://doi.org/10.1182/blood.V104.11.3062.3062
Published: 2004